Comerica Bank’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-79,938
| Closed | -$1.61M | – | 2322 |
|
|
2018
Q1 | $1.61M | Buy |
79,938
+1,755
| +2% | +$34.4K | 0.01% | 1359 |
|
|
2017
Q4 | $1.54M | Sell |
78,183
-191
| -0.2% | -$3.5K | 0.01% | 1427 |
|
|
2017
Q3 | $1.45M | Buy |
78,374
+1,008
| +1% | +$19.3K | 0.01% | 1413 |
|
|
2017
Q2 | $1.45M | Sell |
77,366
-4,111
| -5% | -$60.7K | 0.01% | 1379 |
|
|
2017
Q1 | $1.12M | Buy |
81,477
+2,869
| +4% | +$34.7K | 0.01% | 1557 |
|
|
2016
Q4 | $1.01M | Buy |
78,608
+3,740
| +5% | +$63.9K | 0.01% | 1587 |
|
|
2016
Q3 | $1.78M | Buy |
74,868
+4,713
| +7% | +$127K | 0.02% | 1168 |
|
|
2016
Q2 | $1.64M | Buy |
70,155
+38
| +0.1% | +$1.24K | 0.01% | 1196 |
|
|
2016
Q1 | $2.47M | Buy |
70,117
+1,803
| +3% | +$63.4K | 0.02% | 880 |
|
|
2015
Q4 | $2.62M | Sell |
68,314
-1,397
| -2% | -$55.8K | 0.03% | 791 |
|
|
2015
Q3 | $2.46M | Sell |
69,711
-67,151
| -49% | -$3.03M | 0.02% | 869 |
|
|
2015
Q2 | $6.28M | Buy |
136,862
+69,736
| +104% | +$3.31M | 0.03% | 764 |
|
|
2015
Q1 | $3.15M | Sell |
67,126
-64,188
| -49% | -$2.55M | 0.03% | 766 |
|
|
2014
Q4 | $4.16M | Buy |
131,314
+64,523
| +97% | +$1.89M | 0.02% | 1034 |
|
|
2014
Q3 | $1.58M | Buy |
66,791
+615
| +0.9% | +$15.8K | 0.01% | 1225 |
|
|
2014
Q2 | $1.99M | Sell |
66,176
-1,730
| -3% | -$46.7K | 0.02% | 1098 |
|
|
2014
Q1 | $1.79M | Sell |
67,906
-1,851
| -3% | -$46.3K | 0.01% | 1209 |
|
|
2013
Q4 | $1.75M | Sell |
69,757
-5,524
| -7% | -$123K | 0.01% | 1218 |
|
|
2013
Q3 | $1.54M | Sell |
75,281
-1,440
| -2% | -$29.7K | 0.01% | 1326 |
|
|
2013
Q2 | $1.53M | Buy |
+76,721
| New | +$1.36M | 0.01% | 1119 |
|
Comerica Bank's IPXL Position: Q2 2018 in Review
Comerica Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 79,938 shares — an estimated $1.61M sold.
Comerica Bank first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $6.28M in Q2 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Comerica Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Comerica Bank sold 79,938 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1.61M.
- Comerica Bank first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Comerica Bank's Impax Laboratories, Inc. position peaked at $6.28M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Comerica Bank's 13F filing for Q2 2018, filed 1 Aug 2018.